Vertex pharmaceuticals inc reports quarterly revenue of $949.8 million

Vertex reports third-quarter 2019 financial results.qtrly product revenues of $950 million, a 21% increase compared to q3 2018.qtrly gaap net income per share $0.22.qtrly non-gaap net income per share $1.23.reiterated its full-year 2019 total product revenue guidance.qtrly revenue $949.8 million versus $784.5 million.q3 earnings per share view $1.15, revenue view $950.9 million -- refinitiv ibes data.sees fy 2019 combined gaap research and development and sg&a expenses $2.35 billion to 2.45 billion.
VRTX Ratings Summary
VRTX Quant Ranking